Search research articles
Contact Us
Filters
Showing results (51-60 of 251) with videos related to
Page
of 26
Sort By:
BMC Cancer
|
June 17, 2017
Serial immunomonitoring of cancer patients receiving combined antagonistic anti-CD40 and chemotherapy reveals consistent and cyclical modulation of T cell and dendritic cell parameters
Alison M McDonnell, Alistair Cook, Bruce W S Robinson, et al.
Molecular Therapy. Methods & Clinical Development
|
June 7, 2021
Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing
Eric Alves, Shahama Taifour, Riccardo Dolcetti, et al.
Frontiers in Immunology
|
December 5, 2022
The STING agonist, DMXAA, reduces tumor vessels and enhances mesothelioma tumor antigen presentation yet blunts cytotoxic T cell function in a murine model
Peter T Graham, Anna K Nowak, Scott M J Cornwall, et al.
Respirology Case Reports
|
November 2, 2020
Widespread pulmonary invasion by malignant pleural mesothelioma: an important diagnostic consideration
Mia MacMillan, Bapti Roy, Sally McLaren, et al.
Frontiers in Oncology
|
August 15, 2022
Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action
Caitlin M Tilsed, Scott A Fisher, Anna K Nowak, et al.
Neuro-Oncology Practice
|
December 29, 2025
Healthcare professionals' perspectives on barriers and facilitators to managing brain tumor-related personality and behavior changes
Emma McDougall, Haryana M Dhillon, Lauren J Breen, et al.
International Reviews of Immunology
|
July 19, 2012
The use of agonistic anti-CD40 therapy in treatments for cancer
Andrea Khong, Delia J Nelson, Anna K Nowak, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 23, 2016
PD-L1 on peripheral blood T lymphocytes is prognostic in patients with non-small cell lung cancer (NSCLC) treated with EGFR inhibitors
Tarek M Meniawy, Richard A Lake, Alison M McDonnell, et al.
Molecules (Basel, Switzerland)
|
April 3, 2021
Experimental and Theoretical Mechanistic Study on the Thermal Decomposition of 3,3-diphenyl-4-(trichloromethyl)-5-nitropyrazoline
Karolina Kula, Agnieszka Kącka-Zych, Agnieszka Łapczuk-Krygier, et al.
Journal of Medical Imaging and Radiation Oncology
|
October 29, 2023
The prognostic value of F18 Fluorothymidine positron emission tomography for assessing the response of malignant pleural mesothelioma to chemotherapy - A prospective cohort study
Isaac J May, Anna K Nowak, Roslyn J Francis, et al.
Page
of 26
Search research articles
Search
Showing results (51-60 of 251) with videos related to
Sort By:
Page
of 26
BMC Cancer
|
June 17, 2017
Serial immunomonitoring of cancer patients receiving combined antagonistic anti-CD40 and chemotherapy reveals consistent and cyclical modulation of T cell and dendritic cell parameters
Alison M McDonnell, Alistair Cook, Bruce W S Robinson, et al.
Molecular Therapy. Methods & Clinical Development
|
June 7, 2021
Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing
Eric Alves, Shahama Taifour, Riccardo Dolcetti, et al.
Frontiers in Immunology
|
December 5, 2022
The STING agonist, DMXAA, reduces tumor vessels and enhances mesothelioma tumor antigen presentation yet blunts cytotoxic T cell function in a murine model
Peter T Graham, Anna K Nowak, Scott M J Cornwall, et al.
Respirology Case Reports
|
November 2, 2020
Widespread pulmonary invasion by malignant pleural mesothelioma: an important diagnostic consideration
Mia MacMillan, Bapti Roy, Sally McLaren, et al.
Frontiers in Oncology
|
August 15, 2022
Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action
Caitlin M Tilsed, Scott A Fisher, Anna K Nowak, et al.
Neuro-Oncology Practice
|
December 29, 2025
Healthcare professionals' perspectives on barriers and facilitators to managing brain tumor-related personality and behavior changes
Emma McDougall, Haryana M Dhillon, Lauren J Breen, et al.
International Reviews of Immunology
|
July 19, 2012
The use of agonistic anti-CD40 therapy in treatments for cancer
Andrea Khong, Delia J Nelson, Anna K Nowak, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 23, 2016
PD-L1 on peripheral blood T lymphocytes is prognostic in patients with non-small cell lung cancer (NSCLC) treated with EGFR inhibitors
Tarek M Meniawy, Richard A Lake, Alison M McDonnell, et al.
Molecules (Basel, Switzerland)
|
April 3, 2021
Experimental and Theoretical Mechanistic Study on the Thermal Decomposition of 3,3-diphenyl-4-(trichloromethyl)-5-nitropyrazoline
Karolina Kula, Agnieszka Kącka-Zych, Agnieszka Łapczuk-Krygier, et al.
Journal of Medical Imaging and Radiation Oncology
|
October 29, 2023
The prognostic value of F18 Fluorothymidine positron emission tomography for assessing the response of malignant pleural mesothelioma to chemotherapy - A prospective cohort study
Isaac J May, Anna K Nowak, Roslyn J Francis, et al.
Page
of 26